RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Medical System Holdings Stock

China Medical System Holdings Liabilities 2024

China Medical System Holdings Liabilities

2.21 B CNY

Ticker

867.HK

ISIN

KYG211081248

WKN

A1JLYP

In 2024, China Medical System Holdings's total liabilities amounted to 2.21 B CNY, a -30.14% difference from the 3.16 B CNY total liabilities in the previous year.

China Medical System Holdings Aktienanalyse

What does China Medical System Holdings do?

China Medical System Holdings Ltd is a leading pharmaceutical conglomerate specializing in the development, manufacturing, and marketing of drugs in China. The company was founded in 1995 and is headquartered in Shenzhen. The history of China Medical System began as a small company based in Hong Kong, specializing in the import of drugs from Europe and the United States. In 2004, the company expanded its business into the Chinese market and began marketing products in China. Through a consistent expansion strategy and targeted investments, the company was able to become a major player in the Chinese pharmaceutical market in a short period of time. Today, China Medical System is one of the largest pharmaceutical companies in China with a wide portfolio of products and services. China Medical System's business model is focused on marketing drugs in China. The company works closely with its international partners and licenses their products for the Chinese market. In addition, China Medical System has its own research and development departments that work on developing new drugs for the Chinese market. The various divisions of China Medical System encompass a wide range of products and services. The company operates in the areas of preparative chemistry, clinical development, pharmaceutical distribution, and marketing. The company also offers services such as clinical trials and other consulting services. Some of China Medical System's most well-known products include the anti-tumor drug Endostar, used for the treatment of lung cancer, and the hepatitis B drug Fufangdanshen. The company has also entered into a number of collaboration agreements with international pharmaceutical companies such as Sanofi and Eli Lilly to market their products in China. Overall, the company has built a strong position in the Chinese market throughout its history and makes significant contributions to the research, development, and marketing of drugs in China. China Medical System Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing China Medical System Holdings's Liabilities

China Medical System Holdings's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating China Medical System Holdings's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing China Medical System Holdings's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

China Medical System Holdings's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in China Medical System Holdings’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about China Medical System Holdings stock

What is the level of liabilities of China Medical System Holdings this year?

China Medical System Holdings has a debt balance of 2.21 B CNY this year.

What were the liabilities of China Medical System Holdings compared to the previous year?

The liabilities of China Medical System Holdings have increased by -30.14% dropped compared to the previous year.

What are the consequences of high debt for investors of China Medical System Holdings?

High liabilities can pose a risk for investors of China Medical System Holdings, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in China Medical System Holdings?

Low liabilities mean that China Medical System Holdings has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of China Medical System Holdings affect the company?

An increase in liabilities of China Medical System Holdings can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of China Medical System Holdings affect the company?

A decrease in the liabilities of China Medical System Holdings can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of China Medical System Holdings?

Some factors that can influence the liabilities of China Medical System Holdings include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of China Medical System Holdings so important for investors?

The liabilities of China Medical System Holdings are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can China Medical System Holdings take to modify the liabilities?

To change its liabilities, China Medical System Holdings can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does China Medical System Holdings pay?

Over the past 12 months, China Medical System Holdings paid a dividend of 0.62 CNY . This corresponds to a dividend yield of about 8.53 %. For the coming 12 months, China Medical System Holdings is expected to pay a dividend of 0.69 CNY.

What is the dividend yield of China Medical System Holdings?

The current dividend yield of China Medical System Holdings is 8.53 %.

When does China Medical System Holdings pay dividends?

China Medical System Holdings pays a quarterly dividend. This is distributed in the months of June, June, September, September.

How secure is the dividend of China Medical System Holdings?

China Medical System Holdings paid dividends every year for the past 17 years.

What is the dividend of China Medical System Holdings?

For the upcoming 12 months, dividends amounting to 0.69 CNY are expected. This corresponds to a dividend yield of 9.58 %.

In which sector is China Medical System Holdings located?

China Medical System Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Medical System Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Medical System Holdings from 9/9/2024 amounting to 0.02 CNY, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.

When did China Medical System Holdings pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of China Medical System Holdings in the year 2023?

In the year 2023, China Medical System Holdings distributed 0.616 CNY as dividends.

In which currency does China Medical System Holdings pay out the dividend?

The dividends of China Medical System Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Medical System Holdings

Our stock analysis for China Medical System Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Medical System Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.